Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Clinical trial NCT05465681 · COMPLETED

Trial details

NCT number: NCT05465681
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy

Start date: 2022-08-30
Primary completion: 2023-01-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.